Cargando…

The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019

BACKGROUND: Indonesia suffers from a high burden of tuberculosis (TB) and diabetes (DM). The government initiated national TB-DM co-management activities under the National TB Control Program in 2017. This study investigates the detection and treatment outcomes of TB-DM in Jakarta after implementing...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Weixi, Trimawartinah, Rahman, Fauziah Mauly, Wibowo, Adik, Sanjaya, Adhi, Silitonga, Permata Imani Ima, Tang, Shenglan, Long, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990273/
https://www.ncbi.nlm.nih.gov/pubmed/35395745
http://dx.doi.org/10.1186/s12889-022-13017-y
_version_ 1784683344229826560
author Jiang, Weixi
Trimawartinah
Rahman, Fauziah Mauly
Wibowo, Adik
Sanjaya, Adhi
Silitonga, Permata Imani Ima
Tang, Shenglan
Long, Qian
author_facet Jiang, Weixi
Trimawartinah
Rahman, Fauziah Mauly
Wibowo, Adik
Sanjaya, Adhi
Silitonga, Permata Imani Ima
Tang, Shenglan
Long, Qian
author_sort Jiang, Weixi
collection PubMed
description BACKGROUND: Indonesia suffers from a high burden of tuberculosis (TB) and diabetes (DM). The government initiated national TB-DM co-management activities under the National TB Control Program in 2017. This study investigates the detection and treatment outcomes of TB-DM in Jakarta after implementing these activities, and identifies the main factors associated with these outcomes. METHODS: A cross-sectional study was conducted using TB registry data in two districts of Jakarta, East Jakarta (low-income) and South Jakarta (high-income). A 5-step cascade analysis was used: diagnosed TB patients; TB patients tested for DM; diagnosed TB-DM patients; and patients received and completed TB treatment/cured. We conducted descriptive analyses to understand the characteristics of TB and TB-DM patients, and used a two-level mixed-effect logistic regression to explore factors associated with having a DM test and completing TB treatment/being cured. RESULTS: Over the study period (2017–2019) 50.8% of the new pulmonary TB patients aged over 15 were tested for DM. The percentage increased from 41.7% in 2017–2018 to 60.1% in 2019. Of the TB patients tested for DM, 20.8% were diagnosed with DM. Over 90% of the detected TB-DM patients received standard TB treatment, 86.3% of whom completed treatment/were cured. Patients in East Jakarta were more likely to be tested for DM and to complete standard TB treatment/be cured than patients in South Jakarta (P <  0.001). Bacteriologically positive TB patients were more likely to be tested for DM (OR = 1.37, 95% CIs 1.17,1.60). Patients diagnosed in sub-district level healthcare centers had a higher likelihood of being tested for DM than those in government and private hospitals (P <  0.05). Receiving DM treatment was associated with a higher likelihood of completing TB treatment/being cured (OR = 1.82, 95% CIs 1.20, 2.77). CONCLUSIONS: TB-DM case detection significantly improved in 2019 after introducing TB-DM co-management activities in Jakarta, while gaps in TB-DM co-management existed between bacteriologically positive and clinically diagnosed TB patients, and across different types of health facilities. Collaboration between TB and DM departments should be strengthened, and more resources need to be mobilized to further improve the co-management of TB-DM in Indonesia.
format Online
Article
Text
id pubmed-8990273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89902732022-04-09 The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019 Jiang, Weixi Trimawartinah Rahman, Fauziah Mauly Wibowo, Adik Sanjaya, Adhi Silitonga, Permata Imani Ima Tang, Shenglan Long, Qian BMC Public Health Research BACKGROUND: Indonesia suffers from a high burden of tuberculosis (TB) and diabetes (DM). The government initiated national TB-DM co-management activities under the National TB Control Program in 2017. This study investigates the detection and treatment outcomes of TB-DM in Jakarta after implementing these activities, and identifies the main factors associated with these outcomes. METHODS: A cross-sectional study was conducted using TB registry data in two districts of Jakarta, East Jakarta (low-income) and South Jakarta (high-income). A 5-step cascade analysis was used: diagnosed TB patients; TB patients tested for DM; diagnosed TB-DM patients; and patients received and completed TB treatment/cured. We conducted descriptive analyses to understand the characteristics of TB and TB-DM patients, and used a two-level mixed-effect logistic regression to explore factors associated with having a DM test and completing TB treatment/being cured. RESULTS: Over the study period (2017–2019) 50.8% of the new pulmonary TB patients aged over 15 were tested for DM. The percentage increased from 41.7% in 2017–2018 to 60.1% in 2019. Of the TB patients tested for DM, 20.8% were diagnosed with DM. Over 90% of the detected TB-DM patients received standard TB treatment, 86.3% of whom completed treatment/were cured. Patients in East Jakarta were more likely to be tested for DM and to complete standard TB treatment/be cured than patients in South Jakarta (P <  0.001). Bacteriologically positive TB patients were more likely to be tested for DM (OR = 1.37, 95% CIs 1.17,1.60). Patients diagnosed in sub-district level healthcare centers had a higher likelihood of being tested for DM than those in government and private hospitals (P <  0.05). Receiving DM treatment was associated with a higher likelihood of completing TB treatment/being cured (OR = 1.82, 95% CIs 1.20, 2.77). CONCLUSIONS: TB-DM case detection significantly improved in 2019 after introducing TB-DM co-management activities in Jakarta, while gaps in TB-DM co-management existed between bacteriologically positive and clinically diagnosed TB patients, and across different types of health facilities. Collaboration between TB and DM departments should be strengthened, and more resources need to be mobilized to further improve the co-management of TB-DM in Indonesia. BioMed Central 2022-04-08 /pmc/articles/PMC8990273/ /pubmed/35395745 http://dx.doi.org/10.1186/s12889-022-13017-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jiang, Weixi
Trimawartinah
Rahman, Fauziah Mauly
Wibowo, Adik
Sanjaya, Adhi
Silitonga, Permata Imani Ima
Tang, Shenglan
Long, Qian
The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019
title The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019
title_full The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019
title_fullStr The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019
title_full_unstemmed The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019
title_short The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019
title_sort co-management of tuberculosis-diabetes co-morbidities in indonesia under the national tuberculosis control program: results from a cross-sectional study from 2017 to 2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990273/
https://www.ncbi.nlm.nih.gov/pubmed/35395745
http://dx.doi.org/10.1186/s12889-022-13017-y
work_keys_str_mv AT jiangweixi thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT trimawartinah thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT rahmanfauziahmauly thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT wibowoadik thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT sanjayaadhi thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT silitongapermataimaniima thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT tangshenglan thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT longqian thecomanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT jiangweixi comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT trimawartinah comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT rahmanfauziahmauly comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT wibowoadik comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT sanjayaadhi comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT silitongapermataimaniima comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT tangshenglan comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019
AT longqian comanagementoftuberculosisdiabetescomorbiditiesinindonesiaunderthenationaltuberculosiscontrolprogramresultsfromacrosssectionalstudyfrom2017to2019